Posted on May 1st, 2012 by Health News
Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on the clinical development of epigenetic therapies in solid tumors, announced that previously reported results from ENCORE 401, a randomized, placebo controlled Phase 2 study of erlotinib with or without entinostat in advanced non-small cell lung cancer patients were published in the Journal of Clinical Oncology (JCO).
No Comments »
Filed under: Pharmacy News
Posted on May 1st, 2012 by Health News
UC San Diego Moores Cancer Center researchers and surgeons are among the first in the nation to treat patients with recurrent brain cancer by directly injecting an investigational viral vector into their tumor. The treatment is being developed by a local San Diego Company, Tocagen Inc.
No Comments »
Filed under: Pharmacy News
Posted on April 28th, 2012 by Health News
WASHINGTON (MedPage Today) — The FDA has approved a new indication for everolimus (Afinitor), granting it orphan drug status to treat non-cancerous kidney tumors not requiring immediate surgery in patients with tuberous sclerosis complex.
No Comments »
Filed under: General Health News
Posted on April 28th, 2012 by Health News
Researchers at The Wistar Institute announce the discovery of small molecules that kill cancer cells caused by infection with human papillomavirus (HPV). Their results, in both cell and mouse models, demonstrate that the small molecule inhibitors protect a tumor-suppressing protein targeted by viral proteins, thus killing the infected tumor cells.
No Comments »
Filed under: Pharmacy News
Posted on April 28th, 2012 by Health News
Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Afinitor (everolimus) tablets for the treatment of adult patients with kidney tumors known as renal angiomyolipomas and tuberous sclerosis complex (TSC), who do not require immediate surgery.
No Comments »
Filed under: Pharmacy News
Posted on April 28th, 2012 by Health News
The U.S. Food and Drug Administration today approved Afinitor (everolimus), the first drug approved specifically to treat non-cancerous kidney tumors (renal angiomyolipomas) not requiring immediate surgery in patients with tuberous sclerosis complex.
No Comments »
Filed under: Pharmacy News
Posted on April 20th, 2012 by Health News
Patients with advanced non-small cell lung cancer should only receive treatment with the drug erlotinib before receiving standard chemotherapy if their tumor is known to harbor EGFR mutations, researchers report at the 3rd European Lung Cancer Conference in Geneva, Switzerland.
No Comments »
Filed under: Pharmacy News
Posted on April 20th, 2012 by Health News
Several new studies that may help doctors tailor lung cancer treatment to the characteristics of individual patients and of their tumors are being presented at the 3rd European Lung Cancer Conference in Geneva.
No Comments »
Filed under: Pharmacy News
Posted on April 20th, 2012 by Health News
Medicine-toting nanochains slip into tumors and explode a chemotherapy drug into hard-to-reach cores of cancer, engineers and scientists at Case Western Reserve University report.
No Comments »
Filed under: Pharmacy News
Posted on April 19th, 2012 by Health News
A new brain cancer vaccine tailored to individual patients by using material from their own tumors has proven effective in a multicenter phase 2 clinical trial at extending their lives by several months or longer. The patients suffered from recurrent glioblastoma multiforme-which kills thousands of Americans every year.
No Comments »
Filed under: Pharmacy News
